Most Escherichia coli strains overproducing chromosomal AmpC β-lactamase belong to phylogenetic group A

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 4, 2007, Pages 872-876

  Corvec, Stéphane ^a,b   Prodhomme, Adèle ^a   Giraudeau, Cécile ^a   Dauvergne, Sandie ^b   Reynaud, Alain ^a,b   Caroff, Nathalie ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Cephalosporinase; E. coli; Promoter; Virulence

Indexed keywords

ADHESIN; AEROBACTIN; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CEFALOTIN; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORINASE; EXTENDED SPECTRUM BETA LACTAMASE; HEMOLYSIN; HYDROXAMIC ACID; VIRULENCE FACTOR;

ALLELE; ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMENSAL ESCHERICHIA COLI; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE MUTATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PROMOTER REGION; STRAIN DIFFERENCE;

BACTERIAL PROTEINS; BETA-LACTAMASES; DNA FINGERPRINTING; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA; VIRULENCE FACTORS;

EID: 34548741249     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm284     Document Type: Article

References (11)

1. Caroff N, Espaze E, Bérard I et al. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production. FEMS Microb Lett 1999, 173: 459-65.
2. Tracz DM, Boyd DA, Bryce E et al. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol Lett 2007; 270: 265-71.
3. Bingen-Bidois M, Clermont O, Bonacorsi S et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 2002; 70: 3216-26.
4. Moreno E, Prats G, Sabaté M et al. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 2006; 57: 204-11.
5. Johnson JR, Kuskowski MA, O'Bryan TT et al. Virulence geno-type and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2005; 49: 26-31.
6. Jaurin B, Grundström T. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type. Proc Natl Acad Sci USA 1981; 78: 4897-901.
7. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
8. Pitout JD, Laupland KB, Church DL et al. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 49: 4667-70.
9. Johnson JR, Johnston B, Kuskowski MA et al. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother 2005; 49: 4739-44.
10. Bonacorsi S, Houdouin V, Mariani-Kurkdjian P et al. Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. J Clin Microbiol 2006; 44: 1156-8.
11. Komp Lindgren P, Marcusson LL, Sandvang D et al. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 2005; 49: 2343-51.